Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats.

PubWeight™: 1.15‹?› | Rank: Top 10%

🔗 View Article (PMID 16286809)

Published in Pharmacology on November 11, 2005

Authors

Sameer Sharma1, Muragundla Anjaneyulu, S K Kulkarni, Kanwaljit Chopra

Author Affiliations

1: Pharmacology Division, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh 160-014, India.

Articles citing this

Resveratrol induces mitochondrial biogenesis in endothelial cells. Am J Physiol Heart Circ Physiol (2009) 2.65

Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells. Am J Physiol Heart Circ Physiol (2009) 1.85

Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway. Diabetes (2011) 1.61

Resveratrol: French paradox revisited. Front Pharmacol (2012) 1.40

Alteration of forkhead box O (foxo4) acetylation mediates apoptosis of podocytes in diabetes mellitus. PLoS One (2011) 1.24

Inflammation in the pathogenesis of microvascular complications in diabetes. Front Endocrinol (Lausanne) (2012) 1.24

Sensory neurons and schwann cells respond to oxidative stress by increasing antioxidant defense mechanisms. Antioxid Redox Signal (2009) 1.04

Resveratrol retards progression of diabetic nephropathy through modulations of oxidative stress, proinflammatory cytokines, and AMP-activated protein kinase. J Biomed Sci (2011) 1.03

Renal protective effects of resveratrol. Oxid Med Cell Longev (2013) 0.99

Resveratrol up-regulates SIRT1 and inhibits cellular oxidative stress in the diabetic milieu: mechanistic insights. J Nutr Biochem (2011) 0.95

Effect of sesamol on diabetes-associated cognitive decline in rats. Exp Brain Res (2007) 0.93

Neuroinflammatory responses in diabetic retinopathy. J Neuroinflammation (2015) 0.91

The biological responses to resveratrol and other polyphenols from alcoholic beverages. Alcohol Clin Exp Res (2009) 0.90

Resveratrol and calcium signaling: molecular mechanisms and clinical relevance. Molecules (2014) 0.89

The sustained delivery of resveratrol or a defined grape powder inhibits new blood vessel formation in a mouse model of choroidal neovascularization. Molecules (2014) 0.89

Resveratrol Prevention of Diabetic Nephropathy Is Associated with the Suppression of Renal Inflammation and Mesangial Cell Proliferation: Possible Roles of Akt/NF-κB Pathway. Int J Endocrinol (2014) 0.88

Endothelial Nrf2 activation: a new target for resveratrol? Am J Physiol Heart Circ Physiol (2010) 0.84

Chronic resveratrol treatment restores vascular responsiveness of cerebral arterioles in type 1 diabetic rats. Am J Physiol Heart Circ Physiol (2011) 0.84

An Organ System Approach to Explore the Antioxidative, Anti-Inflammatory, and Cytoprotective Actions of Resveratrol. Oxid Med Cell Longev (2015) 0.82

Resveratrol attenuates azidothymidine-induced cardiotoxicity by decreasing mitochondrial reactive oxygen species generation in human cardiomyocytes. Mol Med Rep (2010) 0.82

Identification by a differential proteomic approach of the induced stress and redox proteins by resveratrol in the normal and diabetic rat heart. J Cell Mol Med (2008) 0.81

Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets. J Diabetes Res (2015) 0.77

Trans-resveratrol inhibits phosphorylation of Smad2/3 and represses FSHβ gene expression by a SirT1-independent pathway in LβT2 gonadotrope cells. Reprod Toxicol (2011) 0.76

Protective effect of resveratrol against aluminum chloride induced nephrotoxicity in rats. Saudi Med J (2016) 0.75

Resveratrol changes spermatogonial stem cells (SSCs) activity and ameliorates their loss in busulfan-induced infertile mouse. Oncotarget (2016) 0.75

A review on chemical and biological properties of Cayratia trifolia Linn. (Vitaceae). Pharmacogn Rev (2011) 0.75

Naturally Occurring Compounds: New Potential Weapons against Oxidative Stress in Chronic Kidney Disease. Int J Mol Sci (2017) 0.75

Articles by these authors

(truncated to the top 100)

Curcumin attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain. Eur J Pharmacol (2006) 1.55

Memory enhancing activity of Glycyrrhiza glabra in mice. J Ethnopharmacol (2004) 1.51

Energetics of nanocrystalline TiO2. Proc Natl Acad Sci U S A (2002) 1.43

Partial agonistic action of clozapine at dopamine D2 receptors in dopamine depleted animals. Psychopharmacology (Berl) (1998) 1.41

Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats. Clin Exp Pharmacol Physiol (2006) 1.38

Probiotics: potential pharmaceutical applications. Eur J Pharm Sci (2002) 1.35

Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: participation of nitric oxide and TNF-alpha. Phytother Res (2007) 1.30

Hesperidin, a citrus bioflavonoid, decreases the oxidative stress produced by carbon tetrachloride in rat liver and kidney. BMC Pharmacol (2005) 1.24

Prescription monitoring of anti-hypertensive drug utilisation at the Panjab University Health Centre in India. Singapore Med J (2004) 1.23

Attenuation of diabetic nephropathy by tocotrienol: involvement of NFkB signaling pathway. Life Sci (2008) 1.22

Possible analgesic and anti-inflammatory interactions of aspartame with opioids and NSAIDs. Indian J Exp Biol (2005) 1.18

Autonomously replicating single-copy episomes in Trypanosoma brucei show unusual stability. EMBO J (1993) 1.16

Quercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats. Clin Exp Pharmacol Physiol (2004) 1.12

Sildenafil-induced peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Brain Res (2001) 1.10

Curcumin attenuates diabetic encephalopathy in rats: behavioral and biochemical evidences. Eur J Pharmacol (2007) 1.10

Suppression of NF-kappabeta signaling pathway by tocotrienol can prevent diabetes associated cognitive deficits. Pharmacol Biochem Behav (2008) 1.08

Curcumin, a polyphenolic antioxidant, attenuates chronic fatigue syndrome in murine water immersion stress model. Immunobiology (2008) 1.08

Effect of curcumin on inflammation and oxidative stress in cisplatin-induced experimental nephrotoxicity. J Agric Food Chem (2007) 1.05

On the antinociceptive effect of fluoxetine, a selective serotonin reuptake inhibitor. Brain Res (2001) 1.05

Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in mice. Brain Res (1997) 1.04

Evaluation of learning and memory mechanisms employing elevated plus-maze in rats and mice. Prog Neuropsychopharmacol Biol Psychiatry (1992) 1.04

Effect of alpha2 agonists clonidine, guanfacine and B-HT 920 on gastric acid secretion and ulcers in rats. Arch Int Pharmacodyn Ther (1985) 1.02

Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging- and dizocilpine-induced learning impairment. Brain Res (1998) 1.00

Comparative brain cholinesterase-inhibiting activity of Glycyrrhiza glabra, Myristica fragrans, ascorbic acid, and metrifonate in mice. J Med Food (2006) 1.00

Microbial synthesis of semiconductor CdS nanoparticles, their characterization, and their use in the fabrication of an ideal diode. Biotechnol Bioeng (2002) 1.00

Curcumin, a diferuloylmethane, attenuates cyclosporine-induced renal dysfunction and oxidative stress in rat kidneys. BMC Pharmacol (2005) 1.00

Sex and estrous cycle-dependent changes in neurosteroid and benzodiazepine effects on food consumption and plus-maze learning behaviors in rats. Pharmacol Biochem Behav (1999) 0.98

Antinociceptive and anti-inflammatory effects of Tanacetum parthenium L. extract in mice and rats. J Ethnopharmacol (1999) 0.98

Influence of biomass and gold salt concentration on nanoparticle synthesis by the tropical marine yeast Yarrowia lipolytica NCIM 3589. Colloids Surf B Biointerfaces (2009) 0.96

Improvement of mouse memory by Myristica fragrans seeds. J Med Food (2004) 0.96

Resveratrol and curcumin suppress immune response through CD28/CTLA-4 and CD80 co-stimulatory pathway. Clin Exp Immunol (2007) 0.95

Chronic treatment with tocotrienol, an isoform of vitamin E, prevents intracerebroventricular streptozotocin-induced cognitive impairment and oxidative-nitrosative stress in rats. Pharmacol Biochem Behav (2009) 0.95

Fluoxetine suppresses morphine tolerance and dependence: modulation of NO-cGMP/DA/serotoninergic pathways. Methods Find Exp Clin Pharmacol (2003) 0.95

Effect of a herbal psychotropic preparation, BR-16A (Mentat), on performance of mice on elevated plus-maze. Indian J Exp Biol (1991) 0.95

Effect of irbesartan on the antioxidant defence system and nitric oxide release in diabetic rat kidney. Am J Nephrol (2004) 0.95

Beneficial effect of hesperidin on lipopolysaccharide-induced hepatotoxicity. Toxicology (2006) 0.94

Antioxidants in the prevention of renal disease. J Med Food (2006) 0.94

Resveratrol prevents alcohol-induced cognitive deficits and brain damage by blocking inflammatory signaling and cell death cascade in neonatal rat brain. J Neurochem (2011) 0.94

Suppression of neuro-inflammatory signaling cascade by tocotrienol can prevent chronic alcohol-induced cognitive dysfunction in rats. Behav Brain Res (2009) 0.93

Effect of sesamol on diabetes-associated cognitive decline in rats. Exp Brain Res (2007) 0.93

Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain. Pharmacol Biochem Behav (2007) 0.93

Protective effect of nitric oxide pathway in resveratrol renal ischemia-reperfusion injury in rats. Arch Med Res (2006) 0.93

Comparative studies on the memory-enhancing actions of captopril and losartan in mice using inhibitory shock avoidance paradigm. Neuropeptides (2001) 0.92

Lycopene attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain. Eur J Pain (2007) 0.91

Analgesic and anti-inflammatory effects of phosphodiesterase inhibitors. Indian J Exp Biol (2000) 0.91

Renal protective effect of molsidomine and L-arginine in ischemia-reperfusion induced injury in rats. J Surg Res (2005) 0.91

The effect of naringin, a bioflavonoid on ischemia-reperfusion induced renal injury in rats. Pharmacol Res (2004) 0.91

Lipopolysaccharide-mediated immobility in mice: reversal by cyclooxygenase enzyme inhibitors. Methods Find Exp Clin Pharmacol (2001) 0.91

Sigma (sigma1) receptor mediated anti-depressant-like effects of neurosteroids in the Porsolt forced swim test. Neuroreport (1998) 0.90

Nitric oxide and major depression. Nitric Oxide (2011) 0.90

Brain renin angiotensin system (RAS) in stress-induced analgesia and impaired retention. Peptides (1999) 0.90

Catechin suppresses an array of signalling molecules and modulates alcohol-induced endotoxin mediated liver injury in a rat model. PLoS One (2011) 0.90

6-Gingerol prevents cisplatin-induced acute renal failure in rats. Biofactors (2006) 0.89

Possible antioxidant mechanism in melatonin reversal of aging and chronic ethanol-induced amnesia in plus-maze and passive avoidance memory tasks. Free Radic Biol Med (2001) 0.89

Melatonin reversal of lipopolysacharides-induced thermal and behavioral hyperalgesia in mice. Eur J Pharmacol (2000) 0.89

Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor. Eur J Pharmacol (2007) 0.89

Molecular interactions of ethanol with GABAergic system and potential of RO15-4513 as an ethanol antagonist. Pharmacol Biochem Behav (1988) 0.89

Effect of resveratrol, a polyphenolic phytoalexin, on thermal hyperalgesia in a mouse model of diabetic neuropathic pain. Fundam Clin Pharmacol (2007) 0.89

Curcumin loaded solid lipid nanoparticles: an efficient formulation approach for cerebral ischemic reperfusion injury in rats. Eur J Pharm Biopharm (2013) 0.89

Lycopene attenuates diabetes-associated cognitive decline in rats. Life Sci (2008) 0.89

Effect of various antiepileptic drugs in a pentylenetetrazol-induced seizure model in mice. Methods Find Exp Clin Pharmacol (2009) 0.89

Quercetin, a bioflavonoid, attenuates thermal hyperalgesia in a mouse model of diabetic neuropathic pain. Prog Neuropsychopharmacol Biol Psychiatry (2003) 0.89

The role of GABA-A and mitochondrial diazepam-binding inhibitor receptors on the effects of neurosteroids on food intake in mice. Psychopharmacology (Berl) (1998) 0.89

Attenuation of oxidative stress, neuroinflammation, and apoptosis by curcumin prevents cognitive deficits in rats postnatally exposed to ethanol. Psychopharmacology (Berl) (2012) 0.88

Neuroprotective effect of N-acetylcysteine in the development of diabetic encephalopathy in streptozotocin-induced diabetes. Metab Brain Dis (2008) 0.88

Antidepressant activity of quercetin, a bioflavonoid, in streptozotocin-induced diabetic mice. J Med Food (2003) 0.88

Antidepressant effect of Valeriana wallichii patchouli alcohol chemotype in mice: Behavioural and biochemical evidence. J Ethnopharmacol (2011) 0.88

Antimutagenic and antioxidant/prooxidant activity of quercetin. Indian J Exp Biol (2005) 0.88

Protective effect of naringin, a bioflavonoid on glycerol-induced acute renal failure in rat kidney. Toxicology (2004) 0.88

Tocotrienol attenuates oxidative-nitrosative stress and inflammatory cascade in experimental model of diabetic neuropathy. Neuropharmacology (2009) 0.88

Fluoxetine attenuates thermal hyperalgesia through 5-HT1/2 receptors in streptozotocin-induced diabetic mice. Eur J Pharmacol (2004) 0.88

Protective effects of nimesulide (COX Inhibitor), AKBA (5-LOX Inhibitor), and their combination in aging-associated abnormalities in mice. Methods Find Exp Clin Pharmacol (2005) 0.87

Elucidation of possible mechanism of analgesic action of Valeriana wallichii DC chemotype (patchouli alcohol) in experimental animal models. Indian J Exp Biol (2010) 0.87

Oxidative stress-mediated renal dysfunction by cyclosporine A in rats: attenuation by trimetazidine. Ren Fail (2002) 0.87

The morphine sparing effect of physostigmine. Methods Find Exp Clin Pharmacol (1999) 0.87

Cyclosporine protects against ischemia/reperfusion injury in rat kidneys. Toxicology (2005) 0.87

Retracted Protective effect of catechin on ischemia-reperfusion-induced renal injury in rats. Pharmacol Rep (2005) 0.87

Possible involvement of sigma-1 receptors in the anti-immobility action of bupropion, a dopamine reuptake inhibitor. Fundam Clin Pharmacol (2008) 0.86

Tocotrienol ameliorates behavioral and biochemical alterations in the rat model of alcoholic neuropathy. Pain (2009) 0.86

Melatonin enhances Th2 cell mediated immune responses: lack of sensitivity to reversal by naltrexone or benzodiazepine receptor antagonists. Mol Cell Biochem (2001) 0.86

Green tea extract and catechin ameliorate chronic fatigue-induced oxidative stress in mice. J Med Food (2005) 0.86

Granulocyte colony stimulating factor (GCSF) improves memory and neurobehavior in an amyloid-β induced experimental model of Alzheimer's disease. Pharmacol Biochem Behav (2013) 0.86

Involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.85

Anti-inflammatory actions of clonidine, guanfacine and B-HT 920 against various inflammagen-induced acute paw oedema in rats. Arch Int Pharmacodyn Ther (1986) 0.85

Template-free ZnS nanorod synthesis by microwave irradiation. Nanotechnology (2008) 0.85

Probiotics: delineation of prophylactic and therapeutic benefits. J Med Food (2009) 0.85

Protective effect of quercetin on alcohol abstinence-induced anxiety and convulsions. J Med Food (2005) 0.85

Heat and other physiological stress-induced analgesia: catecholamine mediated and naloxone reversible response. Life Sci (1980) 0.85

Titania nanoparticles synthesis in mesoporous molecular sieve MCM-41. J Colloid Interface Sci (2007) 0.85

Memory-strengthening activity of Glycyrrhiza glabra in exteroceptive and interoceptive behavioral models. J Med Food (2004) 0.85

The effects of neurosteroids on acquisition and retention of a modified passive-avoidance learning task in mice. Brain Res (1998) 0.85

Protective effect of resveratrol, a polyphenolic phytoalexin on glycerol-induced acute renal failure in rat kidney. Ren Fail (2006) 0.85

Attenuation of renoinflammatory cascade in experimental model of diabetic nephropathy by sesamol. J Agric Food Chem (2009) 0.85

Possible involvement of cholinergic and opioid receptor mechanisms in fluoxetine mediated antinociception response in streptozotocin-induced diabetic mice. Eur J Pharmacol (2006) 0.84

Protective effect of minocycline, a semi-synthetic second-generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity. Toxicology (2007) 0.84

Anti-depressant action of melatonin in chronic forced swimming-induced behavioral despair in mice, role of peripheral benzodiazepine receptor modulation. Eur Neuropsychopharmacol (2000) 0.84

Effect of Spirulina, a blue green algae, on gentamicin-induced oxidative stress and renal dysfunction in rats. Fundam Clin Pharmacol (2006) 0.84

Involvement of cholinergic system in losartan-induced facilitation of spatial and short-term working memory. Neuropeptides (1998) 0.84

Diltiazem attenuates oxidative stress in diabetic rats. Ren Fail (2005) 0.84

Risperidone, an atypical antipsychotic enhances the antidepressant-like effect of venlafaxine or fluoxetine: possible involvement of alpha-2 adrenergic receptors. Neurosci Lett (2008) 0.84